Ministry Of Health Labor And Welfare

dupixent

Pharma

After FDA says no on Dupixent for hives disorder, Japan says yes

Four months after the FDA rejected Sanofi and Regeneron’s Dupixent to treat CSU, Japan has signed off on the treatment in the indication.

Kevin Dunleavy Feb 16, 2024 10:54am

pills

Regeneron-Sanofi's Praluent gets Japan MHLW nod

Jul 5, 2016 9:29am

Japan PM Abe

Japan reshuffles key posts at MHLW

Jun 20, 2016 7:54am

azn

Sanofi gets Japan nod for alirocumab

Jun 6, 2016 12:06am